About Zechowicz Medeusz-Plus Lekarska Spolka Partnerska
"Historia Medeusz-Plus zaczęła się dużo wcześniej niż w 2011 roku, gdy Tadeusz i Maciej Żechowicz założyli spółkę, uruchamiając potem dwie przychodnie – w Olsztynie i w Szczytnie. Prawdziwy początek miał miejsce 38 lat temu, kiedy Tadeusz jako młody lekarz dowiedział się, że będzie miał syna. Był wtedy kierownikiem Poradni Pulmonologicznej w Zakładzie Opieki Zdrowotnej MSWiA w Olsztynie, a zaraz potem asystentem na oddziale wewnętrznym w tym samym szpitalu. Oczywiście nikt nie mógł jeszcze wiedzieć, czy Maciek pójdzie w jego ślady, choć historia lubi układanki, w których z relacji ojciec-syn powstaje coś wyjątkowego."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
2
Clinical Trials at Zechowicz Medeusz-Plus Lekarska Spolka Partnerska
During the past decade, Zechowicz Medeusz-Plus Lekarska Spolka Partnerska conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
2020-09-14
2024-09-13
Active, not recruiting
6,016
A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke
2022-12-05
2025-08-25
Recruiting
18,000
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Zechowicz Medeusz-Plus Lekarska Spolka Partnerska
According to Clinical.Site data, the most researched conditions in "Zechowicz Medeusz-Plus Lekarska Spolka Partnerska" are
"Atrial Fibrillation" (1 trials), "Heart Failure" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Zechowicz Medeusz-Plus Lekarska Spolka Partnerska" in a lesser frequency.
Clinical Trials Intervention Types at Zechowicz Medeusz-Plus Lekarska Spolka Partnerska
Most popular intervention types in "Zechowicz Medeusz-Plus Lekarska Spolka Partnerska" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "Finerenone (BAY94-8862)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Zechowicz Medeusz-Plus Lekarska Spolka Partnerska
The vast majority of trials in "Zechowicz Medeusz-Plus Lekarska Spolka Partnerska" are
2 trials for "All" genders.
Clinical Trials Status at Zechowicz Medeusz-Plus Lekarska Spolka Partnerska
Currently, there are NaN active trials in "Zechowicz Medeusz-Plus Lekarska Spolka Partnerska".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Zechowicz Medeusz-Plus Lekarska Spolka Partnerska,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Zechowicz Medeusz-Plus Lekarska Spolka Partnerska, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".